SARS-CoV-2 Virology

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Jun 2022 English Publisher:Elsevier BVJournal:Infectious Disease Clinics of North America, volume 36, pages 251-265 (issn: 0891-5520,

Copyright policy )Funded by:NIH | Harvard Medical School Ce..., NIH | Harvard University Center...

Authors: Li, Yijia; Li, Jonathan Z.;

doi: 10.1016/j.idc.2022.01.004

pmid: 35636899

pmc: PMC8802625

SARS-CoV-2 Virology

- Summary
- Subjects
- Metrics

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic. In this review, the authors focus on the genomic features of SARS-CoV-2, its intrahost and interhost evolution, viral dynamics in respiratory tract, and systemic dissemination.

Related Organizations

Brigham and Women's Faulkner Hospital
United States
Massachusetts General Hospital
United States
Harvard University
United States

Keywords

SARS-CoV-2, COVID-19, Humans, Antiviral Agents, Pandemics, Article

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	10
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%